Paris, France: The Pfizer vaccine is slightly less effective but still appears to protect against the more transmissible Covid variant found in India, according to a study by the Institut Pasteur in France.
“Despite a slightly reduced efficacy, the Pfizer vaccine probably protects” against the variant found in India, according to the results of laboratory tests, said Olivier Schwartz, director of the institute and co-author of the study which was published. on the BioRxiv site before the peer review. .
The study involved 28 health workers in the city of Orleans. Sixteen of them had received two doses of the Pfizer vaccine, while 12 had received one dose of the AstraZeneca vaccine.
According to the study, people who received two doses of Pfizer saw their antibodies against the B.1.617 variant drop by three, but were still protected.
“The situation was different with the AstraZeneca vaccine, which induced particularly low levels of neutralizing antibodies” the variant, according to the study.
Patients who had had Covid-19 in the past year and people vaccinated with two doses of Pfizer retained enough antibodies to be protected against the variant found in India, but three to six times less antibodies than against the British variant, said Schwartz.
The study shows that “this variant … has acquired partial resistance to antibodies,” said Schwartz.
Since its appearance in late 2019 in China, the SARS-CoV-2 virus that causes Covid-19 has developed several variants, usually named for places where it first appeared, including so-called African strains. from the South and the United Kingdom.
The variant first detected in India appears to be much more transmissible than previous variants.
It has now been officially registered in 53 territories, according to a report from the World Health Organization.
In an attempt to curb its spread, France and Germany have reintroduced stricter rules on arrivals from affected countries, including the United Kingdom.